CBU
NVO

CIBC Bank USA’s Novo Nordisk NVO Stock Holding History

CIBC Bank USA’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,194
Closed -$256K – 302
2014
Q1 		$256K Sell
11,194
-1,446
-11% -$30.8K 0.05% 252
2013
Q4 		$233K Buy
+12,640
New +$220K 0.05% 274

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

CIBC Bank USA's NVO Position: Q2 2014 in Review

CIBC Bank USA sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 11,194 shares — an estimated $256K sold.

CIBC Bank USA first reported a position in NVO in Q4 2013 and held it in 2 quarters. The position peaked at $256K in Q1 2014. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

  • CIBC Bank USA reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
  • CIBC Bank USA sold 11,194 Novo Nordisk shares in Q2 2014, an estimated $256K.
  • CIBC Bank USA first reported a position in Novo Nordisk in Q4 2013 and held it in 2 quarters.
  • CIBC Bank USA's Novo Nordisk position peaked at $256K in Q1 2014.
  • 473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on CIBC Bank USA's 13F filing for Q2 2014, filed 28 Jul 2014.